Xing Liang

Xing Liang has a diverse work experience with a focus on pharmaceuticals and research. Currently, Xing is the Head of CMC at Insilico Medicine since 2021. Prior to that, Xing worked as a Scientist at Roche from 2017 to 2020. Xing also served as the Pharmaceutical synthesis director/Project Lead at Cinkate Corporation from 2014 to 2017. Xing began their career as a Research Assistant at the University of Alabama at Birmingham from 2009 to 2014 and worked as a Research Chemist at Shanghai Recordpharm from 2007 to 2008.

Xing Liang completed a Bachelor of Science (BS) degree in Materials Science from Sun Yat-sen University between 2002 and 2006. Later, from 2009 to 2014, Xing Liang pursued a Doctor of Philosophy (Ph.D.) in Polymer Chemistry at the University of Alabama at Birmingham.